Myomo, Inc. (MYO) stock
MYONYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3035% below fair value
$0.81−0.03 (-3.45%)
Close on Nov 20, 2026Market cap $32.12MP/E –Yield –
Myomo operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Myomo's operating income for the twelve months ending Jun 30, 2026 was -$11.70M. For fiscal 2025 it was -$14.40M. The highest annual figure on record is -$3.28M in fiscal 2016.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$14.40M | – |
| FY2024 | Dec 31, 2024 | -$6.21M | – |
| FY2023 | Dec 31, 2023 | -$8.23M | – |
| FY2022 | Dec 31, 2022 | -$10.67M | – |
| FY2021 | Dec 31, 2021 | -$10.27M | – |
| FY2020 | Dec 31, 2020 | -$10.50M | – |
| FY2019 | Dec 31, 2019 | -$10.80M | – |
| FY2018 | Dec 31, 2018 | -$10.53M | – |
| FY2017 | Dec 31, 2017 | -$6.55M | – |
| FY2016 | Dec 31, 2016 | -$3.28M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.25M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.16M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.77M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.52M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.59M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.52M | – |
| Q4 FY2024 | Dec 31, 2024 | -$245.31K | – |
| Q3 FY2024 | Sep 30, 2024 | -$957.55K | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.12M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.89M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.43M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.02M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.10M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.67M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.23M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.82M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.90M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.74M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.71M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.03M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.60M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.93M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.69M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.55M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.85M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.42M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.58M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.83M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.71M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.68M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.74M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.71M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.68M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.40M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.82M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.43M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.93M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.36M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.10M | – |
| Q3 FY2016 | Sep 30, 2016 | -$933.83K | – |
See a number that looks wrong?